Humoral factor in children with neonatal Bartter syndrome reduces bone calcium uptake in vitro

Pediatric Nephrology

Volumn 12, Issue 5, 1998, Pages 371-376

  Shoemaker, Lawrence R ^a   Bergstrom, William ^b   Ragosta, Kevin ^b   Welch, Thomas R ^c  

^a KOSAIR CHILDREN'S HOSPITAL   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bone; Calcium; Heparin; Neonatal Bartter syndrome

Indexed keywords

BIOLOGICAL FACTOR; CALCIUM; HEPARIN; HEPARIN LYASE; HORMONE ANTIBODY; INDOMETACIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTANOID; PROTAMINE; TRYPSIN;

ARTICLE; BARTTER SYNDROME; BIOASSAY; BLOOD SAMPLING; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM BONE LEVEL; CALCIUM URINE LEVEL; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HYPERCALCIURIA; KIDNEY CALCIFICATION; MINERAL METABOLISM; PRIORITY JOURNAL; URINALYSIS;

ADULT; ANIMALS; BARTTER SYNDROME; BONE AND BONES; CALCIUM; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; HEPARIN; HUMANS; RATS;

EID: 0031875717     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050468     Document Type: Article

References (50)

1. Seyberth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Schärer K (1985) Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107:694-701
2. Dillon MJ, Shah V, Mitchell MD (1979) Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy. Q J Med 48:429-446
3. Rovetto CR de, Welch TR, Hug G, Clark KE, Bergstrom W (1989) Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 115:397-404
4. Proesmans W, Massa G, Vanderschueren-Lodeweyckx M (1988) Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. Pediatr Nephrol 2:205-209
5. Seyberth HW, Koniger SJ, Rascher W, Kuhl PG, Schweer H (1987) Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol 1:491-497
6. Shoemaker L, Welch TR, Bergstrom W, Abrams SA, Yergey AL, Vieira N (1993) Calcium kinetics in the hyperprostaglandin E syndrome. Pediatr Res 33:92-96
7. McCredie DA, Rotenberg E, Williams AL (1974) Hypercalciuria in potassium-losing nephropathy: a variant of Bartter's syndrome. Aust Paediatr J 10:286-295
8. Leonhardt A, Timmermanns G, Roth B, Seyberth HW (1992) Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr 120:546-554
9. Bartter FC, Pronove P, Gill JR, MacCardle RC, Diller E (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. Am J Med 33:811-828
10. Arant BS, Bracken NC, Young RB, Still WJS (1970) Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteromsm associated with severe azotemia and renal rickets: Bartter's syndrome or disease? Pediatrics 46:344-361
11. Wilson DM (1990) Clinical and laboratory evaluation of renal stone patients. Endocrinol Metab Clin North Am 19:773-803
12. Welch TR, Abrams SA, Shoemaker L, Yergey AL, Vieira N, Stuff JE (1995) Precise determination of the absorptive component of urinary calcium excretion using stable isotopes. Pediatr Nephrol 9:295-297
13. Ratovitz J, Miller LA, Stapleton FB (1992) Dietary sodium and the diagnosis of hypercalciuria. Pediatr Res 31:339A
14. Coe FL, Canterbury JM, Firpo JJ, Reiss E (1973) Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 52:134-142
15. Elmgreen J, Tougaard L, Leth A, Christensen MS (1980) Elevated serum parathyroid hormone concentration during treatment with high ceiling diuretics. Eur J Clin Pharmacol 18:363-364
16. Petit WA, Henrich J, Insogna KL, Mitnick MA, Broadus AE (1988) Influence of furosemide on parathyroid hormone levels in hyperparathyroidism. N Engl J Med 318:644-645
17. Venkataraman PS, Han BK, Tsang RC, Daugherty CC (1983) Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. Am J Dis Child 137:1157-1161
18. Reichel H, Deibert B, Geberth S, Schmidt-Gayk H, Ritz E (1992) Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant 7:8-15
19. Vileisis RA (1990) Furosemide effect on mineral status of parenterally nourished premature neonates with chronic lung disease. Pediatrics 85:316-322
20. Kockerling A, Reinalter SC, Seyberth HW (1996) Impaired response to furosemide in hyperprostaglandin E syndrome: Evidence for a tubular defect in the loop of Henle. J Pediatr 129:519-528
21. Simon DB, Karet FE, Hamdan JM, Di Pietro A, Sanjad SA, Lifton RP (1996) Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2CI cotransporter NKCC2 Nat Genet 13:183-188
22. Simon DB, Karet FE, Rodriquez-Soriano J, Hamdan JH, Di Pietro A, Trachtman H, Sanjad SA, Lifton RP (1996) Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14:152-156
23. International Collaborative Study Group for Bartter-like Syndromes (1997) Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. Hum Mol Genet 6:17-26
24. Ohlsson A, Sieck U. Cumming W, Akhtar M, Serenius F (1984) A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria, and nephrocalcinosis. Acta Paediatr Scand 73:868-874
25. Kohout I, Bachmann H (1987) Different types of idiopathic hypercalciuria in children. Monatsschr Kinderheilkd 135:847-850
26. Bett IM, Fraser GP (1958) A rapid micro method for determining serum calcium. Biochem J 68:13P
27. Bergstrom WH (1992) Bone disc bioassay for calciotropic agents. J Bone Miner Res 7:S244
28. Ragosta KG, Bergstrom WH, Briggs DG, Brandt B (1996) Protamine and acute depletion of magnesium limit bone response to parathyroid hormone. Anesth Analg 82:29-32
29. Thompson AR, Counts RB (1976) Removal of heparin and protamine from plasma. J Lab Clin Med 88:922-929
30. 2. Bone 11:61-65
31. Walenga RW, Bergstrom WH (1985) Stimulation of calcium uptake in rat calvaria by prostacyclin. Prostaglandins 29:191-202
32. Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333:166-174
33. Raisz LG (1993) Bone cell biology: New approaches and unanswered questions. J Bone Miner Res 8[Suppl 2]:457-465
34. Bergstrom WH, Williams ML, Jacobs RD, Nervez CT, Gottuso MA (1980) Acute effects of adrenal and ovarian steroids on calcium metabolism. In: De Luca HF, Anast CS (eds) Pediatric diseases related to calcium. Elsevier, New York, pp 217-228
35. Hakanson DO, Bergstrom WH (1982) Prevention of light-induced hypocalcemia by melatonin. In: Norman AW, Schaefer K, Herrath DV, Grigoleit HG (eds) Vitamin D: chemical, biological and clinical endocrinology of calcium metabolism. Proceedings of the Fifth Workshop on Vitamin D, Williamsburg, Va, February 1982. de Gruyter, Berlin, pp 1163-1165
36. Schurman SJ, Bergstrom WH, Root AW, Souid AK, Hannan WP (1997) Interleukm-1 beta mediated calciotropic activity in serum of children with juvenile rheumatoid arthritis. J Rheumatol (in press)
37. Fuller K, Chambers TJ, Gallagher AC (1991) Heparin augments osteoclast resorption-stimulating activity in serum. J Cell Physiol 147:208-214
38. Ginsberg JS, Hirsh J (1989) Use of anticoagulants during pregnancy. Chest 95[Suppl 2]:156S-160S
39. Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R, Coates G, Webber C (1990) Heparin effect on bone density. Thromb Haemost 64:286-289
40. Griffith GC, Nichols G, Ashker JD, Flanagan B (1965) Heparin osteoporosis. JAMA 193:85-88
41. Sackler JP, Liu L (1973) Heparin-induced osteoporosis. Br J Radiol 46:548-550
42. Squires JW, Pinch LW (1979) Heparin-induced spinal fractures. JAMA 241:2417-2418
43. Hirsh J (1991) Heparin. N Engl J Med 324:1565-1574
44. Chowdhury MH, Hamada C, Dempster DW (1992) Effects of heparin on osteoclast activity. J Bone Miner Res 7:771-777
45. Hahnemann S (1965) Heparin and osteoporosis. Lancet II: 855-856
46. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M (1986) Growth factors in bone matrix. J Biol Chem 261: 12665-12674
47. Canalis E, Centrella M (1986) Isolation of a nontransforming bone-derived growth factor from medium conditioned by fetal rat calvariae. Endocrinology 118:2002-2008
48. Simmons HA, Raisz LG (1991) Effects of acid and basic fibroblast growth factor and heparin on resorption of cultured fetal rat long bones. J Bone Miner Res 6:1301-1305
49. Kessler MN, Raisz LG, Hurley MM (1993) Interactive effects of basic fibroblast growth factor and heparin on bone in 21-day fetal rat calvariae. Conn Med 57:9-11
50. Tashjian AH, Voelkel EF, Lazzaro M, Singer FR, Roberts AB, Derynck R, Winkler ME, Levine L (1985) a and α human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci USA 82:4535-4538